complications which are associated with a more severe renal injury. Background. Since 1971, 55 case-reports of rifampicininduced ARF have been published, but systematic data on this condition are not available, in view of the Key words: acute renal failure (ARF ); rifampicin; disparate nature of the observations. haemolytic anaemia; thrombocytopenia; hepatic injury Methods. We retrospectively assessed prevalence, clinical and biochemical features, and prognostic factors of 60 consecutive cases (41 males/19 females, age 22-68 years), who were admitted to the Iasi Dialysis Centre Introduction from 1987 to 1995 for acute renal failure (ARF ) following re-treatment with rifampicin.
The files of patients with post-rifampicin ARF hospitalized normal size kidneys.
The following data was collected for each patient: demographic data, serum creatinine value before the renal failure Haematological disorders event, liver function tests, before and during the ARF (serum protein electrophoresis, ASAT, ALAT, bilirubinaemia, fib-Anaemia was observed in 57 patients (96%) with a rinogenaemia, prothrombin time), renal tests (BUN, serum mean Hct at admission of 32±4.5%. Twenty-three creatinine, Addis-Hamburger test, 24-h urine tests), haema-patients had mild anaemia (Hct >35%), 25 patients tological tests (Hct, WBC-total and differential count, plate-had a Hct of 30-35%, and 12 patients had more severe let count) and the duration of the oligoanuric phase (days). anaemia with a Hct <30%. Leukocytosis >10 000/ml The biochemical and haematological assays were recorded was found in 38 patients (60.6%) (mean value on admission, and 30 and 90 days from onset. Normal values 12 395±4312/ml ), four patients had eosinophilia as described by [58] were used for all haematological and (>500/ml ) and 30 patients had thrombocytopenia biochemical variables.
(<150 000/ml ). Although reticulocytosis (>100 000/ml )
The data was analysed using the CSTAT statistic package Fifty-seven patients (96%) were anuric at presentation. in our haemodialysis centre during this period.
The duration of the anuric phase was on average, 11.4±7 days. An average of 4.8±4.6 haemodialyClinical features sis sessions per patient were required. Thirty days after the first day of anuria, the mean BUN level The symptoms and signs at presentation are described in Table 1 . ARF occurred immediately after reintro-was 0.33±0.14 g/l, with 15 patients in the normal range, and the mean serum creatinine level was duction of the rifampicin treatment (mean dose until onset of first clinical symptoms, 600±300 mg). The 2.38±2.20 mg/dl, with 25 patients in the normal range.
Urinalysis abnormalities were found in most patients: interval from the last rifampicin treatment varied from 21 days to 1 year. Mean dosage/week of the previous 20 cases (33%) with haematuria, 10 cases (16.6%) with haemoglobinuria, and 36 cases (60%) with proteinuria rifampicin treatment was 1200 mg. Clinical signs appeared 20±12 h after restarting tratment. In 55 >0.5 g/24 h (1 case in nephrotic range). Previously reported light-chain proteinuria [35, 56 ] was evaluated cases rifampicin was indicated as part of antituberculous regimens. In Moldavia, the geographic area served and found negative in nine patients. Sterile leukocyturia (abnormal leukocyturia at the Addis-Hamburger by the Iasi Haemodialysis Centre, 120 132 cases of tuberculosis were treated in the same period test, but with sterile urine cultures), considered as a marker of interstitial nephritis, was present in 50 cases (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) , resulting a 0.05% incidence of postrifampin ARF in these patients.
(83%). With the exception of one case with transient glycosuria, hyperchloraemic acidosis, and maintained these two groups; the differences are presented in Table 4 . diuresis, no other tubular defects were seen in our cohort. Biopsies were performed in only five patients, There was a direct correlation between the number of HD sessions and the length of the anuric phase (r= taking into account the usual favourable course seen by us and described by others [9] , and the range of 0.47, P=0.001). Also, patients with higher creatinine levels at 30 days after injury had a longer period of histopathological lesions expected (risk-benefit odds ratio analysis). Four cases had tubulointerstitial neph-anuria; positive correlation between these two parameters (r=0.48, P=0.002). The patients with hyperritis and one tubular necrosis; no glomerular lesions were seen and IF was negative. gammaglobulinaemia (n=13) had a significantly longer anuric phase than those without hypergammaglobulinaemia (15.5±4.2 days vs 10.4±7.7 days respectHepatic injury ively; P=0.05). There was a direct correlation between Hepatic injury was considered in the presence of hepa-the level of serum gammaglobulins and the duration tocytolytic syndrome and either hypergammaglobuli-of anuria in all patients (r=0.49, P<0.05; Figure 1 ). naemia or low prothrombin time and it was found in During the study period there was one death (1.66%) 15 patients. The mean values of the main hepatic tests among the 60 patients with post-rifampicin ARF, are presented in Table 3 . There were no significant compared to a 20% mortality rate of all ARF cases differences concerning demography, haematology, and hospitalized in the same period (P<0.05). Moreover, renal function (as reflected by azotaemia at onset and this death was attributed to the generalized extension 30 days from onset and by the number of haemodialysis of tuberculosis, with pulmonary miliary lesions and sessions) between the patients with hepatic injury and meningitis. There was no need for further renal replacethe rest of the patients. ment therapy in any of the patients. Ninety days from onset, serum creatinine and BUN were normal in 57 patients, and abnormal but <2 mg/dl, in two patients.
Evolution, prognostic factors
No correlation was seen between the severity of renal failure (assessed by length of the anuric phase, number Discussion of HD sessions, initial serum creatinine level, serum creatinine level at 30 and 90 days from injury), and Rifampicin is an antibacterial agent largely used in the the rifampicin dose that induced ARF, or the total treatment of tuberculosis, a disease with an increasing dose of the last rifampicin treatment, or the time from prevalence. There have been reports of rifampicin this last treatment.
toxicity, both in continuous administration [13,14, In order to assess the short-term prognostic factors, [16] [17] [18] [19] 21, 22, 27, 36 ] and especially in discontinuous we divided the patients into two groups: those who administration [1] [2] [3] [4] [5] [6] [7] [8] 15, [23] [24] [25] [26] 28, [30] [31] [32] [37] [38] [39] [40] [41] [42] , as a had a normal serum creatinine 30 days after the onset result of type II and rarely type III hypersensitivity of disease (n=25), and those who did not (n=35). We reactions. The range of rifampicin toxicity was compared several clinical and biological parameters in described in 55 isolated case reports published between 1971 and 1995, most of them coming from countries frequently secondary to disseminated intravascular coagulation induced by haemolysis [27, 28] . The more severe the anaemia, the more frequent the presence of reference [7] ) after the first treatment. There was no haemolysis and thrombocytopenia ( Table 2) , thus cerrelationship between the pre-ARE/injury dose, last tifying the severity of the immune process. Indeed, a treatment dose, or time from last treatment of rifamcorrelation between the presence and severity of the picin and the clinical or biological manifestations, haematological signs and the titre of circulating rifamsimilar to that initially described by Poole . Massive association with a previous normal renal function and intravascular haemolysis was also often associated with absence of other potential causes for ARF, established haemoglobinuria ( Table 2) and probably with more rifampicin as the sole aetiology. Therefore, routine severe renal injury (produced by both immune and examination for antirifampicin antibodies was not contoxic mechanisms) and consequently a longer anuric sidered necesary. Also, post-rifampicin ARF cases phase and slower recovery of renal function, with without demonstrable circulating antibodies [9, 21, 34] significantly higher serum creatinine levels persisting have been described. When investigated, (five cases), after 30 days from injury ( Table 4 ). The correlation their presence was confirmed, as reported by between the importance of the immune abnormalities [8, 26, 27, 32, 44] . Finally, after risk/benefit odds anaand the severity of renal damage is also supported by lysis, renal biopsy was not considered essential for a the direct correlation between the serum gammaglobupositive diagnosis. Biopsy was performed in five cases, lin level and the duration of anuria found by us, as revealing only interstitial lesions with normal glomerwell as by the unexpectedly high frequency of immunoular appearance.
globulin deposits previously described in the literature The most frequent symptoms were gastrointestinal (abdominal pain, nausea, vomiting and diarrhoea) [3,4,10,47].
Simultaneous signs of hepatic injury (a true hepator-worsen the renal injury and therefore the evolution of the disease. enal failure) were found in 25% of cases, more often than have been previously reported [31] [32] [33] [34] . The
The severity of the immune processes and the duration of the anuric phase are the main short-term reason might be pre-existing liver disease despite normal biochemical tests, such as chronic hepatitis prognostic factors. The long-term evolution is usually favourable in the large majority of cases. possibly induced by the antituberculous drugs themselves. However, hepatic injury, did not affect the outcome, in our patients.
Sterile leukocyturia, found in 83% of patients at presentation, is a marker of interstitial nephritis caus-References ing the ARF [27, 32, 36 ] . 
